Turn £10k Into £30k With AstraZeneca plc

AstraZeneca plc (LON: AZN) would have trebled your money in 10 years.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

AstraZenecaIf you’d held AstraZeneca (LSE: AZN) (NYSE: AZN.US) shares over the past 12 months, you’d have done pretty nicely with a 40% rise to 4,544p.

A lot of that is down to the Pfizer bid, mind, but the turnaround plan put in place by new boss Pascal Soriot was already boosting the shares. And over three years you’d be sitting on a gain of more than 60%.

But Fools are in it for the long term, so what would an investment in AstraZeneca a full 10 years ago be worth now?

Double your money

In September 2004, AstraZeneca shares were changing hands for around 2,265p, so if you’d invested £10,000 at the time you would have picked up 442 shares. Wind forward to today, and with AstraZeneca shares priced at 4,544p you’d have enjoyed a 101% capital gain — you’d have more than doubled your £10,000 in 10 years to £20,062.

Bear in mind that the period covered two traumatic events for AstraZeneca. One was the recession that hit the entire FTSE, but we also had the so-called patent cliff that saw the end of protection of some key drugs. Between late 2006 and early 2008, AstraZeneca shares lost a massive 49%, and investors could be forgiven for not being too impressed by the stock market at the time.

But even if you’d bought in at the very peak of 2006 and suffered the crunch, your shares would still be worth 30% more today! As failures go, I’ve seen worse.

Don’t forget the dividends

If that 10-year doubling impressed you, don’t forget there’s more to come in the shape of dividends. Early in the decade, AstraZeneca was handing out yields of between 2% and 3%, which was a little below the FTSE 100 average. But the dividend was on the rise, and by 2009 it was yielding 5% — and it got as high as 6.1% in 2011.

Altogether, the annual cash handout would have netted you an additional £5,617, giving you a total of £25,679 for an overall return of 157%.

But we don’t want to give you that!

Buy more shares!

No, if you hadn’t needed to spend your dividends, you’d have built an even bigger pot had you reinvested the cash in more AstraZeneca shares every year.

Just those few extra few shares every year would have added another £4,471 to your investment! That’s an extra 45% return on your original £10,000.

Your total gain with all dividends reinvested over 10 years? A pretty cool £30,150! And you’d be starting the next decade with 639 shares instead of your original 442.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Suddenly investors can’t get enough of GSK shares! What’s going on?

After years in the doldrums, GSK shares are suddenly the most bought stock on the entire FTSE 100. Harvey Jones…

Read more »

'2024' art concept overlaid on a stock screener
Investing Articles

£5,000 invested in Greggs shares in October 2024 is now worth…

Despite facing a multitude of challenges today, might Greggs' stock be worth a look after losing well over a third…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Where will Rolls-Royce shares go next? Let’s ask the experts

Rolls-Royce shares have wobbled as aviation uncertainty grows. But can the City's glowing forecasts help get the price climbing again?

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

No savings at 45? Here’s how investors could still build a £17,360 second income

It’s never too late to start investing, and with compounding working over time, Andrew Mackie shows how investors could still…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How to invest £10,000 to aim for a £6,108 annual passive income

UK REITs have been getting a lot of attention. But our author thinks they're still the place to look for…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

What sort of passive income stream could you build for a fiver a day?

Think a few pounds a day might not go far? In fact, that could be the basis of some pleasing…

Read more »

British Isles on nautical map
Investing Articles

I sense a potential opportunity if the FTSE 100 loses this quality growth stock…

Rightmove falling out of the FTSE 100 might have been unthinkable a year ago. But that's the reality investors are…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The largest S&P 500 holding in my ISA is…

Edward Sheldon's making a large bet on this S&P 500 stock. Because he sees the long-term risk/reward proposition very attractive.

Read more »